Abstract
Abstract
Background
Chargemaster prices are the list prices that providers and health systems assign to each of their medical services in the US. These charges are often several factors of magnitude higher than those extended to individuals with either private or public insurance, however, these list prices are billed in full to uninsured patients, putting them at increased risk of catastrophic health expenditures (CHE). The objective of this study was to examine the risk of CHE across insurance status, diabetes diagnosis and to examine disparity gaps across race/ethnicity.
Methods
We perform a retrospective observational study on a nationally representative cohort of adult patients from the Medical Expenditure Panel Survey for the years 2002–2017. Using logistic regression models we estimate the risk of CHE across insurance status, diabetes diagnosis and explore disparity gaps across race/ethnicity.
Results
Our fully adjusted results show that the relative odds of having CHE if uninsured is 5.9 (p < 0.01) compared to if insured, and 1.1 (p < 0.01) for patients with a diabetes diagnosis (compared to those without one). We note significant interactions between insurance status and diabetes diagnosis, with uninsured patients with a diabetes diagnosis being 9.5 times (p < 0.01) more likely to experience CHE than insured patients without a diabetes diagnosis. In terms of racial/ethnic disparities, we find that among the uninsured, non-Hispanic blacks are 13% (p < 0.05), and Hispanics 14.2% (p < 0.05), more likely to experience CHE than non-Hispanic whites. Among uninsured patients with diabetes, we further find that Hispanic patients are 39.3% (p < 0.05) more likely to have CHE than non-Hispanic white patients.
Conclusions
Our findings indicate that uninsured patients with diabetes are at significantly elevated risks for CHE. These risks are further found to be disproportionately higher among uninsured racial/ethnic minorities, suggesting that CHE may present a channel through which structural economic and health disparities are perpetuated.
Funder
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute on Minority Health and Health Disparities
Publisher
Springer Science and Business Media LLC
Reference54 articles.
1. Agency for Healthcare Research and Quality (AHRQ). Medical expenditure panel survey. Full year consolidated data files. [cited 2021 Apr 29];Available from: https://meps.ahrq.gov/mepsweb/data_stats/data_overview.jsp
2. Agency for Healthcare Research and Quality (AHRQ). Medical expenditure panel survey. Survey Background. [cited 2021 Apr 29];Available from: https://meps.ahrq.gov/mepsweb/about_meps/survey_back.jsp
3. Andersen R, Newman FJ. Societal and Individual Determinants of Medical Care Utilization in the United States. Milbank Q. 2005;83(4):1–28.
4. Anderson GF. From “soak the rich” to “soak the poor”: Recent trends in hospital pricing. Health Aff. 2007;26(3):780–9.
5. Antonisse L, Garfield R, Rudowitz R, Artiga S. The effects of Medicaid expansion under the ACA: updated findings from a literature review. Published March. 2018. https://scholar.google.com/scholar?hl=en&as_sdt=0%2C44&q=Antonisse+L%2C+Garfield+R%2C+Rudowitz+R%2C+Artiga+S.+The+effects+of+Medicaid+expansion+under+the+ACA%3A+updated+findings+from+a+literature+review.+Published.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献